On July 20, 2022, Mr. Chanan Morris notified the board of directors of Artemis Therapeutics Inc. regarding his resignation from his position as Chief Financial Officer of the Company, effective immediately. Mr. Morris' resignation was not due to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. On July 25, 2022, Board of Directors appointed Mr. David Dana to act as Chief Financial Officer, effective July 26, 2022.

Mr. David Dana, age 58, is a Certified Public Accountant (ISR) and holds an MBA in Business Administration from Heriot Watt University in the UK. Over the last 12 years Mr. Dana has been the owner of CFO4U, an Israeli company providing external financial and accounting services to various companies. From 2013 to 2017, Mr. Dana provided financial services to Riskified Ltd. Mr. Dana has been providing financial services to Joytunes Ltd. since 2011, to Powtoon Ltd. and Powtoon Limited since 2013, to Tradair Ltd. since 2013, and to Substrata Ltd. since 2013.